Ulrike Jaegle

Ulrike Jaegle currently holds the position of VP Global Regulatory Affairs & Preclinical Safety at CureVac, a role part of a career that includes significant leadership in regulatory affairs, having served as VP Global Regulatory Affairs and Exec Director Global Regulatory Affairs at the same company since July 2020. Prior experience includes serving as VP of Regulatory Affairs at Apogenix and roles in regulatory affairs at Sandoz Biopharmaceuticals. Additionally, Ulrike Jaegle held positions in research and development and regulatory policy at Novartis International AG. Educational qualifications include a Ph.D. in Cell Biology and Genetics from Erasmus University Rotterdam and a Diploma in Biology with a focus on Genetics, Cell Biology, Biochemistry, and Physical Chemistry from The University of Freiburg.